Andrea Oneglia

Andrea studied Biotechnology and conducted his Ph.D. in Molecular Biology in Cambridge (UK) focusing on rare genetic and epigenetic syndromes. During his research period, he applied genetic engineering approaches (CRISPR-Cas9) to research needs in the generation of animal and cell models. He concluded his postdoc experience in Montreal (Canada) where he gave his contribution in the characterization of cardiovascular diseases.